Carboxylesterase-2 plays a critical role in dabigatran etexilate active metabolite formation
- 18 October 2022
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 47, 100479
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (R15GM096074)
- National Institutes of Health
This publication has 36 references indexed in Scilit:
- Lipopolysaccharide down-regulates carbolesterases 1 and 2 and reduces hydrolysis activity in vitro and in vivo via p38MAPK–NF-κB pathwayToxicology Letters, 2011
- In Vitro Evaluation of Inhibitory Effects of Antidiabetic and Antihyperlipidemic Drugs on Human Carboxylesterase ActivitiesDrug Metabolism and Disposition, 2010
- Different Inhibitory Effects in Rat and Human CarboxylesterasesDrug Metabolism and Disposition, 2009
- The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in HumansDrug Metabolism and Disposition, 2008
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran EtexilateClinical Pharmacokinetics, 2008
- Interleukin-6 Alters the Cellular Responsiveness to Clopidogrel, Irinotecan, and Oseltamivir by Suppressing the Expression of Carboxylesterases HCE1 and HCE2Molecular Pharmacology, 2007
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBritish Journal of Clinical Pharmacology, 2007
- Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small IntestineDrug Metabolism and Disposition, 2006
- FUNCTIONAL CHARACTERIZATION OF THREE NATURALLY OCCURRING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE CES2 GENE ENCODING CARBOXYLESTERASE 2 (HCE-2)Drug Metabolism and Disposition, 2005
- Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 genePharmacogenetics, 2004